See if You Qualify The Ozempic Blood Clot Lawsuit is an active lawsuit See If You Qualify A 2021 study has linked Ozempic, a semaglutide used to lower blood sugar levels and promote weight loss in individuals with Type 2 diabetes and obesity, to an increased risk of blood clots, including deep vein thrombosis (DVT) and pulmonary embolisms
Lastly, potential changes in cardiovascular markers, such as blood pressure and cholesterol levels, may represent additional benefits of semaglutide
When body weight is gained, the skin stretches to accommodate increased fat, damaging collagen and elastin fibers and reducing the skins ability to snap back after weight loss
Carry a comprehensive letter from your prescriber naming the active ingredient (semaglutide or tirzepatide), dosage, and medical necessity
Ozempic Belongs to a Class of Powerful Drugs Called GLP-1 Receptor Agonists
Read: Does Drinking Water Help You Lose Weight